IP Library › Granted Patent US 9,155,729
Granted Patent B2
US 9,155,729 · App. 14/585,619 · Granted Oct 13, 2015

Thiazolidinedione analogues

Inventors: Gerard R. Colca (Kalamazoo, MI); Rolf F. Kletzien (Richland, MI)
Assignee: Metabolic Solutions Development Company, LLC
A61K31/4439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,155,729
App. No.
14/585,619
Granted
Oct 13, 2015
Kind
B2
Abstract

The present invention relates to thiazolidinedione analogs that are useful for treating metabolic inflammation mediated diseases such as diabetes.

Claims (2)

1. A method of treating Parkinson's disease comprising administering to a patient a pharmaceutical composition comprising Compound No. 1:

or a pharmaceutically acceptable salt thereof.

Assignments (2)
SECURITY INTEREST Recorded May 3, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: ALZHEIMER DRUG DISCOVERY FOUNDATION
Reel/Frame 038447/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: COLCA, GERARD R.; KLETZIEN, ROLF F.
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 035073/0853 →
Continuity (6)
Continuation 13751672 · Jan 28, 2013
Division 13068708 · May 18, 2011
Continuation 12283811 · Sep 16, 2008
Continuation In Part PCTUS2007006321 · Mar 14, 2007
Provisional Application 60782894 · Mar 16, 2006
Related Publication 20150190385A1 · Jul 9, 2015